| 000 | 00932 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250513105235.0 | ||
| 264 | 0 | _c19970306 | |
| 008 | 199703s 0 0 eng d | ||
| 022 | _a1350-6277 | ||
| 024 | 7 |
_a10.1177/174182679600300401 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBuring, J E | |
| 245 | 0 | 0 |
_aAntioxidants and coronary heart disease: weighing the totality of the evidence. _h[electronic resource] |
| 260 |
_bJournal of cardiovascular risk _cAug 1996 |
||
| 300 |
_a343-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xmetabolism |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCoronary Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aHennekens, C H | |
| 773 | 0 |
_tJournal of cardiovascular risk _gvol. 3 _gno. 4 _gp. 343-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/174182679600300401 _zAvailable from publisher's website |
| 999 |
_c8938571 _d8938571 |
||